scispace - formally typeset
K

Ketil Heimdal

Researcher at Oslo University Hospital

Publications -  65
Citations -  2448

Ketil Heimdal is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 25, co-authored 65 publications receiving 2024 citations. Previous affiliations of Ketil Heimdal include Rikshospitalet–Radiumhospitalet.

Papers
More filters
Journal ArticleDOI

Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review.

TL;DR: The pathogenetic mechanisms of HELLP syndrome are reviewed with an emphasis on differences between HELLP and early onset PE.
Journal ArticleDOI

The Y deletion gr/gr and susceptibility to testicular germ cell tumor

TL;DR: Data indicate that the Y microdeletion gr/gr is a rare, low-penetrance allele that confers susceptibility to TGCT.
Journal ArticleDOI

Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

Asbjørg Stray-Pedersen, +96 more
TL;DR: This high‐throughput genomic approach enabled detection of disease‐related variants in unexpected genes; permitted detection of low‐grade constitutional, somatic, and revertant mosaicism; and provided evidence of a mutational burden in mixed PIDD immunophenotypes.
Journal ArticleDOI

Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.

Marie E. Faughnan, +54 more
TL;DR: The expert panel generated and approved 6 new recommendations that highlight new evidence in existing topics from the first International HHT Guidelines and provide guidance in 3 new areas: anemia, pediatrics, and pregnancy and delivery.
Journal ArticleDOI

Genome-wide linkage screen for testicular germ cell tumour susceptibility loci

TL;DR: The results indicate that no single major locus can account for the majority of the familial aggregation of TGCT, and suggests that multiple susceptibility loci with weak effects contribute to the disease.